Digest Network Come funziona
Network
/
Società
Io
Non verificato

Ionis Pharmaceuticals, Inc.

Di cosa scriviamo

BiotecnologiaFarmaceuticaMedicina - VarieSaluteScienza

58 comunicati stampa

Guarda tutti i comunicati
21/04/2026
Eventi
Fiere
Industria
Salute
Igiene alimentare
Sanità
Medicina - Varie
Farmaceutica
Biotecnologia
Ionis presents new data from pivotal study of zilganersen in Alexander disease (AxD) at AAN 2026 Annual Meeting
Fonte
Ionis Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
15/04/2026
Web e Social Network
Telefonia e Varie
Finanza
Mercato azionario
Salute
Biotecnologia
Farmaceutica
Cardiologia
Ionis to hold first quarter 2026 financial results webcast
Fonte
Ionis Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
23/03/2026
Industria
Salute
Igiene alimentare
Biotecnologia
Medicina - Varie
Farmaceutica
Ionis announces zilganersen New Drug Application for Alexander disease (AxD) accepted by FDA for Priority Review
Fonte
Ionis Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
09/03/2026
Mercato del lavoro
Biotecnologia
Farmaceutica
Salute
Ionis announces changes to Board of Directors
Fonte
Ionis Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
27/02/2026
Eventi
Salute
Biotecnologia
Scienza
Farmaceutica
Ionis to present new data supporting DAWNZERA™ (donidalorsen) in hereditary angioedema at 2026 AAAAI Annual Meeting
Fonte
Ionis Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
26/02/2026
Industria
Scienza
Igiene alimentare
Biotecnologia
Medicina - Varie
Cardiologia
Salute
Farmaceutica
Olezarsen sNDA accepted by the FDA for Priority Review for the treatment of severe hypertriglyceridemia (sHTG)
Fonte
Ionis Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
25/02/2026
Web e Social Network
Telefonia e Varie
Mercato azionario
Biotecnologia
Farmaceutica
Salute
Ionis reports fourth quarter and full year 2025 financial results and highlights progress on key programs
Fonte
Ionis Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
19/02/2026
Eventi
Web e Social Network
Salute
Biotecnologia
Medicina - Varie
Scienza
Farmaceutica
Ionis to present at upcoming investor conferences
Fonte
Ionis Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
17/02/2026
Web e Social Network
Telefonia e Varie
Finanza
Mercato azionario
Salute
Biotecnologia
Farmaceutica
Cardiologia
Ionis updates time for fourth quarter and full year 2025 financial results webcast
Fonte
Ionis Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
11/02/2026
Web e Social Network
Telefonia e Varie
Finanza
Mercato azionario
Salute
Biotecnologia
Farmaceutica
Cardiologia
Ionis to hold fourth quarter and full year 2025 financial results webcast
Fonte
Ionis Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0